ArticleJournal of pharmacy & bioallied sciences2025
A Cross-Sectional Study to Assess the Level of Antioxidant Ascorbic Acid (Vitamin C) in Diagnosed Patients of Depression at Tertiary Care Hospital of Central India.
Article in Journal of pharmacy & bioallied sciences, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Vitamin C is a potent antioxidant that protects biomolecules from oxidative stress and damage. Depression is a psychiatric disorder characterized by low mood, loss of interest, and diminished energy. The role of oxidative stress in depression remains unclear, with conflicting findings in the literature. This study aimed to evaluate the serum levels of vitamin C in patients with depression compared to healthy individuals and to assess its correlation with depression severity. Materials and Methods: A cross-sectional study involves 55 newly diagnosed drug-naive patients with depression and 55 healthy controls. Serum vitamin C levels were measured and compared. The severity of depression was assessed using the Hamilton Rating Scale for Depression (HRSD). Results: The mean serum vitamin C levels were significantly lower in depressed patients (0.1569 ± 0.12 mg/dl) compared to healthy controls (1.4629 ± 0.93 mg/dl) ( Conclusion: Vitamin C deficiency is more pronounced in patients with depression, particularly in severe cases. The findings suggest that vitamin C may play a role in the pathophysiology of depression and that supplementation could be beneficial in managing the disease.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.